Stock Yards Bank & Trust Company lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 3.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,682 shares of the healthcare conglomerate’s stock after selling 121 shares during the period. Stock Yards Bank & Trust Company’s holdings in UnitedHealth Group were worth $433,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. Kistler-Tiffany Companies increased its stake in UnitedHealth Group by 15.5% in the fourth quarter. Kistler-Tiffany Companies now owns 3,387 shares of the healthcare conglomerate’s stock valued at $398,000 after buying an additional 454 shares during the period. Eagle Asset Management increased its stake in UnitedHealth Group by 82.8% in the third quarter. Eagle Asset Management now owns 76,396 shares of the healthcare conglomerate’s stock valued at $8,862,000 after buying an additional 34,611 shares during the period. Jennison Associates increased its stake in UnitedHealth Group by 0.7% in the third quarter. Jennison Associates now owns 399,902 shares of the healthcare conglomerate’s stock valued at $46,393,000 after buying an additional 2,902 shares during the period. Finally, Janus Capital Management increased its stake in UnitedHealth Group by 21.4% in the third quarter. Janus Capital Management now owns 3,312,800 shares of the healthcare conglomerate’s stock valued at $384,318,000 after buying an additional 583,578 shares during the period.

UnitedHealth Group Inc (NYSE:UNH) traded down 0.85% during mid-day trading on Thursday, reaching $111.38. 3,525,571 shares of the company traded hands. The firm has a market cap of $107.70 billion and a PE ratio of 18.53. The stock’s 50-day moving average price is $114.98 and its 200-day moving average price is $117.41. UnitedHealth Group Inc has a one year low of $95.00 and a one year high of $126.21.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.02. The business earned $43.60 billion during the quarter, compared to analyst estimates of $43.26 billion. During the same quarter in the prior year, the company posted $1.55 EPS. The company’s quarterly revenue was up 30.4% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Inc will post $7.73 earnings per share for the current fiscal year.

Several equities research analysts recently issued reports on the stock. FBR & Co. dropped their price target on shares of UnitedHealth Group from $135.00 to $130.00 and set an “outperform” rating on the stock in a research note on Thursday, November 19th. Jefferies Group dropped their target price on shares of UnitedHealth Group to $142.00 and set a “buy” rating for the company in a research report on Friday, November 20th. BMO Capital Markets dropped their target price on shares of UnitedHealth Group from $139.00 to $130.00 in a research report on Friday, November 20th. Raymond James dropped their target price on shares of UnitedHealth Group from $146.00 to $140.00 and set a “strong-buy” rating for the company in a research report on Friday, November 20th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $148.00 target price on shares of UnitedHealth Group in a research report on Wednesday, December 2nd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $140.48.

In other news, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction on Monday, November 23rd. The shares were sold at an average price of $114.13, for a total value of $1,141,300.00. Following the completion of the transaction, the director now owns 67,357 shares in the company, valued at approximately $7,687,454.41. The sale was disclosed in a filing with the SEC, which is available at this link.

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace, including payers, care providers, employers, Governments, life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical, emotional and financial needs of individuals. OptumInsight provides technology, operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (NYSE:UNH) services.

12 Month Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.